Electrochemical CO2 reduction reaction (CO2RR) is of importance for reducing global CO2 emissions. Herein, we reported a high active CO2RR catalyst Co-N-Ni/NPCNSs, which is considered as an advanced single-site catalyst...
Metal-organic framework (MOF) derived single-atom catalysts (SACs), featured unique active sites and adjustable topological structures, exhibit high electrocatalytic performance on carbon dioxide reduction reactions (CO2RR). By modulating elements and atomic...
Great enthusiasm in single-atom catalysts for various catalytic reactions continues to heat up. However, the poor activity of the existing single/dual-metal-atom catalysts does not meet the actual requirement. In this scenario, the precise design of triple-metal-atom catalysts is vital but still challenging. Here, a triple-atom site catalyst of FeCoZn catalyst coordinated with S and N, which is doped in the carbon matrix (named FeCoZn-TAC/SNC), is designed. The FeCoZn catalyst can mimic the activity of oxidase by activating O 2 into • O 2 − radicals by virtue of its atomically dispersed metal active sites. Employing this characteristic, triple-atom catalysts can become a great driving force for the development of novel biosensors featuring adequate sensitivity. First, the property of FeCoZn catalyst as an oxidase-like nanozyme was explored. The obtained FeCoZn-TAC/SNC shows remarkably enhanced catalytic performance than that of FeCoZn-TAC/NC and single/dual-atom site catalysts (FeZn, CoZn, FeCo-DAC/NC and Fe, Zn, Co-SAC/NC) because of trimetallic sites, demonstrating the synergistic effect. Further, the utility of the oxidase-like FeCoZn-TAC/SNC in biosensor field is evaluated by the colorimetric sensing of ascorbic acid. The nanozyme sensor shows a wide concentration range from 0.01 to 90 μM and an excellent detection limit of 6.24 nM. The applicability of the nanozyme sensor in biologically relevant detection was further proved in serum. The implementation of TAC in colorimetric detection holds vast promise for further development of biomedical research and clinical diagnosis.
Heterogeneous catalysts, as crucial industrial commodities, play an important role in industrial production, especially in energy catalysis. Traditional noble metal catalysts cannot meet the increasing demand. Therefore, the exploration of...
Hydrogen is the most preferred choice as an energy source to replace the nonrenewable energy resources such as fossil fuels due to its beneficial features of abundance, ecofriendly, and outstanding gravimetric energy density. Splitting water through a proton exchange membrane (PEM) electrolyzer is a well‐known method of hydrogen production. But the major impediment is the sluggish kinetics of oxygen evolution reaction (OER). Currently, scientists are struggling to build out an acid‐stable electrocatalyst for OER with low overpotential and excellent stability. In this review, the reaction mechanism and characterization parameters of OER are introduced, and then the improvement method of metal nanocatalysts (noble metal catalysts and noble metal‐free catalysts) in acidic media is discussed. Particularly, the application of single‐atom catalysts in acidic OER is summarized, which is current researching focus. At the same time, we also briefly introduced the cluster phenomenon, which is easy to occur in the preparation of single‐atom catalysts. More importantly, we summarized the in situ characterization methods such as in situ X‐ray absorption spectroscopy, in situ X‐ray photoelectron spectroscopy, and so forth, which are conducive to further understanding of OER reaction intermediates and active sites. Finally, we put forward some opinions on the development of acidic OER.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.